The Senate today passed and sent to the president for his signature the Formula Act (H.R. 8351), bipartisan legislation that would suspend tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage to help health care providers and families locate formula.

Related News Articles

Headline
The House Energy and Commerce Subcommittee on Health Feb. 29 held a hearing on legislative proposals to expand access to treatment for patients with rare…
Headline
Part of a special series exploring how hospitals and health systems are addressing the medical complications that can accompany pregnancy, this podcast shares…
Headline
Iowa, Massachusetts, Maryland, Michigan, Minnesota and New Mexico will participate in a new Department of Health and Human Services collaborative that will…
Headline
The Department of Health and Human Services Feb. 14 named several hospital and health system programs final phase winners in its national competition to…
Headline
Syphilis infections during pregnancy more than tripled between 2016 and 2022 to 280 cases per 100,000 births, ranging from 46 per 100,000 in Maine to 763 per…
Headline
Learn how hospitals and health systems are improving maternal and child health outcomes in this synopsis of the latest resources from AHA’s Better Health for…